Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Joseph Eid, M.D. as Executive Vice ...

Two days after a seismic election that many saw as a referendum on gender progress in the United States, 9,000 women descended on the Convention Center for the annual Pennsylvania Conference for Women ...

BioSpace, the leader in biopharma news and careers has published its 2025 Best Places to Work list. BioSpace's Best Places to ...

Earlier in his career, he served as CFO at multiple publicly-traded biotech companies including Sirna Therapeutics, a genetic ...

These include the Coca-Cola Co. (KO) at $275 billion and Merck & Co. (MRK) at $260 billion ... journalist with experience in both breaking and business news. Earlier in her career, she reported on the ...

Then, out of nowhere, Frank’s life unravelled after his wife announced that she wanted a divorce. Mixed with the shock and heartbreak came a realisation that financial planning, which he had always ...

Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...

NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Merck, Singapore * Rajesh Krishnamurthy, Chief Executive Officer, Laurus Bio * Tine Rorvik, Global Director Climate Impact & ...

Iovance Biotherapeutics' strong Q3 earnings and promising drug pipeline suggest growth potential for risk-tolerant investors.

Intellia Therapeutics' NTLA-2002 Phase II results last month were underwhelming, however, management reassured investors on ...